AIDS Therapy

Sustained reduction in AIDS seen since introduction of HAART

Published in AIDS Weekly, July 21st, 2003

European research highlights how the introduction of highly active antiretroviral therapy has had a sustained effect in reducing illness and death from HIV/AIDS over the past few years.

Highly active antiretroviral therapy was introduced around 1996 and immediately brought about a substantial reduction in illness and death for people with HIV-1 infection. Amanda Mocroft from the Royal Free and University College Medical School, London, and colleagues investigated whether the short-term benefits of HAART have been sustained by prospectively analyzing around 9800 patients with HIV/AIDS across 70 centers in Europe, Israel, and Argentina.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-07-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry